{"count": 18, "results": [{"_id": "34420660", "pmid": 34420660, "title": "TAMEing ADPKD with metformin: safe and effective?", "journal": "Kidney Int", "authors": ["Ong ACM", "Gansevoort RT"], "date": "2021-09-01T00:00:00Z", "doi": "10.1016/j.kint.2021.07.021", "meta_date_publication": "2021 Sep", "meta_volume": "100", "meta_issue": "3", "meta_pages": "513-515", "score": 50286.84, "text_hl": "TAMEing @<m>DISEASE_Polycystic_Kidney_Diseases</m> @DISEASE_MESH:D007690 @@@ADPKD@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@: safe and effective?", "citations": {"NLM": "Ong ACM, Gansevoort RT. TAMEing ADPKD with metformin: safe and effective? Kidney Int. 2021 Sep;100(3):513-515. PMID: 34420660", "BibTeX": "@article{34420660, title={TAMEing ADPKD with metformin: safe and effective?}, author={Ong ACM and Gansevoort RT}, journal={Kidney Int}, volume={100}, number={3}, pages={513-515}}"}}, {"_id": "40352899", "pmid": 40352899, "title": "Challenges and Considerations in Metformin Use for ADPKD: A Commentary on Recent Findings.", "journal": "Indian J Nephrol", "authors": ["Patil AN", "Singh MP", "Rawat P", "Sah S", "Satapathy P"], "date": "2025-05-01T00:00:00Z", "doi": "10.25259/IJN_513_2024", "meta_date_publication": "2025 May-Jun", "meta_volume": "35", "meta_issue": "3", "meta_pages": "443", "score": 50278.273, "text_hl": "Challenges and Considerations in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use for @<m>DISEASE_Polycystic_Kidney_Diseases</m> @DISEASE_MESH:D007690 @@@ADPKD@@@: A Commentary on Recent Findings.", "citations": {"NLM": "Patil AN, Singh MP, Rawat P, Sah S, Satapathy P. Challenges and Considerations in Metformin Use for ADPKD: A Commentary on Recent Findings. Indian J Nephrol. 2025 May-Jun;35(3):443. PMID: 40352899", "BibTeX": "@article{40352899, title={Challenges and Considerations in Metformin Use for ADPKD: A Commentary on Recent Findings.}, author={Patil AN and Singh MP and Rawat P and Sah S and Satapathy P}, journal={Indian J Nephrol}, volume={35}, number={3}, pages={443}}"}}, {"_id": "33127449", "pmid": 33127449, "title": "Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease.", "journal": "J Control Release", "authors": ["Wang J", "Chin D", "Poon C", "Mancino V", "Pham J", "Li H", "Ho PY", "Hallows KR", "Chung EJ"], "date": "2021-01-10T00:00:00Z", "doi": "10.1016/j.jconrel.2020.10.047", "meta_date_publication": "2021 Jan 10", "meta_volume": "329", "meta_issue": "", "meta_pages": "1198-1209", "score": 50273.3, "text_hl": "Oral delivery of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ by @CHEMICAL_Chitosan @CHEMICAL_MESH:D048271 @@@chitosan@@@ nanoparticles for @<m>DISEASE_Polycystic_Kidney_Diseases</m> @DISEASE_MESH:D007690 @@@polycystic kidney disease@@@.", "citations": {"NLM": "Wang J, Chin D, Poon C, Mancino V, Pham J, Li H, Ho PY, Hallows KR, Chung EJ. Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease. J Control Release. 2021 Jan 10;329():1198-1209. PMID: 33127449", "BibTeX": "@article{33127449, title={Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease.}, author={Wang J and Chin D and Poon C and Mancino V and Pham J and Li H and Ho PY and Hallows KR and Chung EJ}, journal={J Control Release}, volume={329}, pages={1198-1209}}"}}, {"_id": "36660586", "pmid": 36660586, "title": "Combining Metformin and Drug-Loaded Kidney-Targeting Micelles for Polycystic Kidney Disease.", "journal": "Cell Mol Bioeng", "authors": ["Jiang K", "Huang Y", "Chung EJ"], "date": "2022-12-22T00:00:00Z", "doi": "10.1007/s12195-022-00753-9", "meta_date_publication": "2023 Feb", "meta_volume": "16", "meta_issue": "1", "meta_pages": "55-67", "score": 50273.3, "text_hl": "Combining @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and Drug-Loaded Kidney-Targeting Micelles for @<m>DISEASE_Polycystic_Kidney_Diseases</m> @DISEASE_MESH:D007690 @@@Polycystic Kidney Disease@@@.", "citations": {"NLM": "Jiang K, Huang Y, Chung EJ. Combining Metformin and Drug-Loaded Kidney-Targeting Micelles for Polycystic Kidney Disease. Cell Mol Bioeng. 2023 Feb;16(1):55-67. PMID: 36660586", "BibTeX": "@article{36660586, title={Combining Metformin and Drug-Loaded Kidney-Targeting Micelles for Polycystic Kidney Disease.}, author={Jiang K and Huang Y and Chung EJ}, journal={Cell Mol Bioeng}, volume={16}, number={1}, pages={55-67}}"}}, {"_id": "38512373", "pmid": 38512373, "title": "A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials.", "journal": "J Nephrol", "authors": ["Stanley IK", "Palma AM", "Viecelli AK", "Johnson DW", "Hawley CM", "Staatz CE", "Mallett AJ"], "date": "2024-03-21T00:00:00Z", "doi": "10.1007/s40620-024-01906-x", "meta_date_publication": "2024 Mar 21", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50267.06, "text_hl": "A secondary analysis of concurrent use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Tolvaptan @CHEMICAL_MESH:D000077602 @@@tolvaptan@@@ in @<m>DISEASE_Polycystic_Kidney_Diseases</m> @DISEASE_MESH:D007690 @@@ADPKD@@@ @CHEMICAL_Tolvaptan @CHEMICAL_MESH:D000077602 @@@tolvaptan@@@ trials.", "citations": {"NLM": "Stanley IK, Palma AM, Viecelli AK, Johnson DW, Hawley CM, Staatz CE, Mallett AJ. A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials. J Nephrol. 2024 Mar 21;():. PMID: 38512373", "BibTeX": "@article{38512373, title={A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials.}, author={Stanley IK and Palma AM and Viecelli AK and Johnson DW and Hawley CM and Staatz CE and Mallett AJ}, journal={J Nephrol}}"}}, {"_id": "34186056", "pmid": 34186056, "title": "Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD).", "journal": "Kidney Int", "authors": ["Perrone RD", "Abebe KZ", "Watnick TJ", "Althouse AD", "Hallows KR", "Lalama CM", "Miskulin DC", "Seliger SL", "Tao C", "Harris PC", "Bae KT"], "date": "2021-09-01T00:00:00Z", "doi": "10.1016/j.kint.2021.06.013", "meta_date_publication": "2021 Sep", "meta_volume": "100", "meta_issue": "3", "meta_pages": "684-696", "score": 50266.81, "text_hl": "Primary results of the randomized trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration in @<m>DISEASE_Polycystic_Kidney_Diseases</m> @DISEASE_MESH:D007690 @@@polycystic kidney disease@@@ (TAME @DISEASE_Familial_paroxysmal_dystonia @DISEASE_MESH:C537180 @@@PKD@@@).", "citations": {"NLM": "Perrone RD, Abebe KZ, Watnick TJ, Althouse AD, Hallows KR, Lalama CM, Miskulin DC, Seliger SL, Tao C, Harris PC, Bae KT. Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD). Kidney Int. 2021 Sep;100(3):684-696. PMID: 34186056", "BibTeX": "@article{34186056, title={Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD).}, author={Perrone RD and Abebe KZ and Watnick TJ and Althouse AD and Hallows KR and Lalama CM and Miskulin DC and Seliger SL and Tao C and Harris PC and Bae KT}, journal={Kidney Int}, volume={100}, number={3}, pages={684-696}}"}}, {"_id": "34156429", "pmid": 34156429, "title": "The cellular pathways and potential therapeutics of Polycystic Kidney Disease.", "journal": "Biochem Soc Trans", "authors": ["Richards T", "Modarage K", "Malik SA", "Goggolidou P"], "date": "2021-06-30T00:00:00Z", "doi": "10.1042/BST20200757", "meta_date_publication": "2021 Jun 30", "meta_volume": "49", "meta_issue": "3", "meta_pages": "1171-1188", "score": 50263.44, "text_hl": "The cellular pathways and potential therapeutics of @<m>DISEASE_Polycystic_Kidney_Diseases</m> @DISEASE_MESH:D007690 @@@Polycystic Kidney Disease@@@.", "citations": {"NLM": "Richards T, Modarage K, Malik SA, Goggolidou P. The cellular pathways and potential therapeutics of Polycystic Kidney Disease. Biochem Soc Trans. 2021 Jun 30;49(3):1171-1188. PMID: 34156429", "BibTeX": "@article{34156429, title={The cellular pathways and potential therapeutics of Polycystic Kidney Disease.}, author={Richards T and Modarage K and Malik SA and Goggolidou P}, journal={Biochem Soc Trans}, volume={49}, number={3}, pages={1171-1188}}"}}, {"_id": "40352872", "pmid": 40352872, "title": "Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease - A Randomized Control Trial.", "journal": "Indian J Nephrol", "authors": ["Venkatasubramanian V", "Sethi J", "Kumar V", "Yadav AK", "Lal A", "Kohli HS"], "date": "2025-05-01T00:00:00Z", "doi": "10.25259/IJN_100_2024", "meta_date_publication": "2025 May-Jun", "meta_volume": "35", "meta_issue": "3", "meta_pages": "410-416", "score": 50260.473, "text_hl": "Conclusion: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ appears to be safe and well tolerated in nondiabetic @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Polycystic_Kidney_Diseases</m> @DISEASE_MESH:D007690 @@@ADPKD@@@.", "citations": {"NLM": "Venkatasubramanian V, Sethi J, Kumar V, Yadav AK, Lal A, Kohli HS. Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease - A Randomized Control Trial. Indian J Nephrol. 2025 May-Jun;35(3):410-416. PMID: 40352872", "BibTeX": "@article{40352872, title={Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease - A Randomized Control Trial.}, author={Venkatasubramanian V and Sethi J and Kumar V and Yadav AK and Lal A and Kohli HS}, journal={Indian J Nephrol}, volume={35}, number={3}, pages={410-416}}"}}, {"_id": "36755918", "pmid": 36755918, "pmcid": "PMC9900736", "title": "Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis", "journal": "Front Endocrinol (Lausanne)", "authors": ["Peng Q", "Chen X", "Liang X", "Ouyang J", "Wang Q", "Ren S", "Xie H", "Wang C", "Sun Y", "Wu X", "Liu H", "Hei C", "Sun M", "Chang Q", "Liu X", "Li G", "He R"], "date": "2023-01-23T00:00:00Z", "doi": "10.3389/fendo.2023.1070264", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1070264", "score": 50248.504, "text_hl": "Morphological results showed that after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment, @<m>DISEASE_Polycystic_Kidney_Diseases</m> @DISEASE_MESH:D007690 @@@polycystic lesions@@@ in @DISEASE_Ovarian_Neoplasms @DISEASE_MESH:D010051 @@@ovaries@@@ were reduced, the ovarian function was restored, and the expressions of @GENE_SIRT3 @GENE_64384 @@@SIRT3@@@ and @GENE_GPX4 @GENE_625249 @@@GPX4@@@ were elevated. ", "citations": {"NLM": "Peng Q, Chen X, Liang X, Ouyang J, Wang Q, Ren S, Xie H, Wang C, Sun Y, Wu X, Liu H, Hei C, Sun M, Chang Q, Liu X, Li G, He R. Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis Front Endocrinol (Lausanne). 2023;14():1070264. PMID: 36755918", "BibTeX": "@article{36755918, title={Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis}, author={Peng Q and Chen X and Liang X and Ouyang J and Wang Q and Ren S and Xie H and Wang C and Sun Y and Wu X and Liu H and Hei C and Sun M and Chang Q and Liu X and Li G and He R}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1070264}}"}}, {"_id": "40855441", "pmid": 40855441, "title": "Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.", "journal": "Trials", "authors": ["Pierre KS", "El-Damanawi R", "Johnson DW", "Hawley CM", "Viecelli AK", "Jha V", "Green SC", "Gesualdo L", "Kiriwandeniya C", "Velayudham P", "Vergara LA", "Mihala G", "Matsuyama M", "Brent PP", "Mallett AJ", "IMPEDE-PKD Global Steering Committee (see Appendix)"], "date": "2025-08-25T00:00:00Z", "doi": "10.1186/s13063-025-09010-6", "meta_date_publication": "2025 Aug 25", "meta_volume": "26", "meta_issue": "1", "meta_pages": "302", "score": 50246.605, "text_hl": "Implementation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Therapy to Ease Decline of Kidney Function in @<m>DISEASE_Polycystic_Kidney_Diseases</m> @DISEASE_MESH:D007690 @@@Polycystic Kidney Disease@@@ (IMPEDE-@DISEASE_Familial_paroxysmal_dystonia @DISEASE_MESH:C537180 @@@PKD@@@): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in slowing the rate of kidney function decline in @SPECIES_9606 @@@patients@@@ with @DISEASE_Polycystic_Kidney_Autosomal_Dominant @DISEASE_MESH:D016891 @@@autosomal dominant polycystic kidney disease@@@.", "citations": {"NLM": "Pierre KS, El-Damanawi R, Johnson DW, Hawley CM, Viecelli AK, Jha V, Green SC, Gesualdo L, Kiriwandeniya C, Velayudham P, Vergara LA, Mihala G, Matsuyama M, Brent PP, Mallett AJ, IMPEDE-PKD Global Steering Committee (see Appendix). Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease. Trials. 2025 Aug 25;26(1):302. PMID: 40855441", "BibTeX": "@article{40855441, title={Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.}, author={Pierre KS and El-Damanawi R and Johnson DW and Hawley CM and Viecelli AK and Jha V and Green SC and Gesualdo L and Kiriwandeniya C and Velayudham P and Vergara LA and Mihala G and Matsuyama M and Brent PP and Mallett AJ and IMPEDE-PKD Global Steering Committee (see Appendix)}, journal={Trials}, volume={26}, number={1}, pages={302}}"}}]}